CARSON CITY, Nev.--(BUSINESS WIRE)--XYTOS (the “Company”) (OTC: XYTS) Shares Patient Results. Tim Cook, Chairman and CEO of XYTOS, Inc., commented, “We offer a sampling of our patient results in an effort to educate readers on the benefits of the XYTOS Treatment. It is important to understand that the XYTOS treatment is not a substitute for surgery in breast cancer patients and although it can be beneficial to many patients, the treatment will not help all cancer patients. The XYTOS treatment focuses on metastasis, not large tumors with limited blood supply. The XYTOS treatment is an alternative to Chemotherapy, Radiation and Hormone therapy, without the side effects associated with these conventional treatments. Note that our patient results are to extensive to post here but additional results for Breast, Skin and Prostate Cancer Patients are available for review on the XYTOS website at www.xytos.com”
